Thousand Oaks, CA, United States of America

Filisaty Vounatsos

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Filisaty Vounatsos in Pharmaceutical Development

Introduction

Filisaty Vounatsos is an accomplished inventor based in Thousand Oaks, California, known for his significant contributions to pharmaceutical innovations. With a total of four patents under his name, Vounatsos is recognized for his expertise in developing novel processes and crystalline forms of compounds that can inhibit MDM2, a protein that plays a role in cancer progression.

Latest Patents

Among Vounatsos's latest patents is a groundbreaking invention focused on the processes of making and crystalline forms of an MDM2 inhibitor. The patent outlines the processes for creating the compound 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, alongside the intermediates and methods for producing these intermediates. Additionally, the patent details the crystalline forms of the compound and its intermediates, showcasing Vounatsos's innovative approach to drug formulation.

Career Highlights

Currently, Filisaty Vounatsos is employed at Amgen Inc., a leading biotechnology company renowned for its commitment to developing advanced therapies and treatments. Over the years, Vounatsos has focused his research on drug development, particularly in the field of oncology, demonstrating his dedication to addressing significant health challenges.

Collaborations

In his career, Vounatsos has had the opportunity to work alongside notable colleagues such as Sebastien Caille and Matthew Bio. Their collaboration further highlights the importance of teamwork in the research and development of novel pharmaceutical solutions, ensuring a multifaceted approach to challenges in the industry.

Conclusion

Filisaty Vounatsos's contributions to the field of pharmaceuticals reflect his innovative spirit and commitment to improving healthcare outcomes. His work on MDM2 inhibitors is a testament to the impact that dedicated inventors can have on medical advancements. As he continues to develop new pathways for drug formulation, the pharmaceutical community looks forward to the future innovations that Vounatsos will undoubtedly bring to light.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…